Bio-Gene Technology Ltd. (AU:BGT) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Bio-Gene Technology Limited has released its 2024 Annual Report, revealing a significant decrease in revenue from the previous year by 87.7% but also a 22.2% reduction in losses after tax. Despite the challenging financial results, the company’s focus remains on developing bio-insecticides to tackle insecticide resistance, and no dividends have been declared. The full report, including a detailed review of operations and the audited financial statements, is available on the company’s website.
For further insights into AU:BGT stock, check out TipRanks’ Stock Analysis page.